Articles

The new guidelines from the ACC and AHA would increase the number of individuals eligible for statin therapy by nearly 13 million people.… 

A study shows GLP-1 agonists slow the acceleration of gastric emptying that occurs as a result of insulin-induced hypoglycemia…. Glucagon-like peptide 1 (GLP-1) receptor agonists are used as monotherapy, secondary therapy with other oral agents, and in combination with basal insulin for management of type 2 diabetes. Though they are …

Researchers track data on antidiabetic prescriptions dispensed from retail pharmacies in the US and note some interesting prescribing patterns. What is the most antidiabetic drug dispensed?… See more SGLT-2 Resources Despite the ability of nonpharmacological methods such as lifestyle interventions and bariatric surgery to improve type 2 diabetes outcomes, most …

Moderation is key when it comes to diabetes and alcoholic beverages…. 

The use of insulin pumps during pregnancy could be beneficial…. 

Agavins are non-digestible natural sugars which may have future applications in diabetes and weight loss by increasing the GLP-1 hormone…. 

Statins will lower cholesterol and increase weight in diabetic patients…. 

Cohort study determines how patient outcomes have changed since multifactorial treatment of CV risk factors and RAS inhibition have become standard of care…. 

The results of adding vildagliptin to metformin…. 

Myocardial infarction (MI) patients who are hospitalized and are hyperglycemic may have increased risk for diabetes….